108th CONGRESS
1st Session
S. 1666
To amend the Public Health Service Act to establish comprehensive
State diabetes control and prevention programs, and for other purposes.
IN THE SENATE OF THE UNITED STATES
September 26, 2003
Mr. COCHRAN (for himself and Mr. KENNEDY) introduced the following bill;
which was read twice and referred to the Committee on Health, Education, Labor,
and Pensions
A BILL
To amend the Public Health Service Act to establish comprehensive
State diabetes control and prevention programs, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United
States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the `Diabetes Prevention and Treatment Act'.
SEC. 2. FINDINGS.
Congress finds the following:
(1) Diabetes occurs in 2 forms, type 1 and type 2 diabetes. Type 1 diabetes
usually occurs during childhood or adolescence and type 2 diabetes, which
accounts for more than 9 out of 10 cases of diabetes, usually occurs after
age 40. Type 1 diabetes is a disease that results from the body's failure
to produce insulin, the hormone that `unlocks' the cells of the body, allowing
glucose, or sugar, to enter and fuel the cells. People with type 1 diabetes
must take daily insulin injections to stay alive. Type 2 diabetes results
from insulin resistance, a condition in which the body cannot properly use
insulin and cannot make enough insulin to compensate for the increased bodily
need. Although some people with type 2 diabetes also require daily insulin
injections, often type 2 diabetes can be controlled through healthy diet,
nutrition, and lifestyle changes. If not, medication and insulin shots may
be used to control diabetes.
(2) There are approximately 17,000,000 individuals in the United States
with diabetes, almost 1/3 of whom are unaware that they have the disease.
(3) Diabetes is the sixth leading cause of death in the United States, contributing
to over 200,000 deaths every year.
(4) Another 16,000,000 individuals in the United States have a condition
known as `pre-diabetes', or impaired glucose tolerance. Unless treated,
`pre-diabetes' dramatically increases the risk for developing type 2 diabetes
and increases the risk of heart disease by nearly 50 percent.
(5) Prevention efforts against type 2 diabetes that consisted of diet and
exercise (such as cutting fat and calories and walking at least 30 minutes,
5 days a week, resulting in a 5- to 7-percent weight loss) lowered the incidence
of type 2 diabetes by 58 percent.
(6) There is a growing epidemic of type 2 diabetes in children and adolescents
that may be linked to obesity and physical inactivity. Type 2 diabetes now
accounts for between 8 and 46 percent of all new cases of diabetes among
children who are referred to pediatric centers for care.
(7) Diabetes is also a major contributor to heart disease, stroke, and high
blood pressure. In adults, diabetes is the leading cause of new blindness,
end-stage renal failure, and nontraumatic lower limb amputations. People
with diabetes are 2 to 4 times more likely than the general population to
have heart disease or to suffer a stroke.
(8) Diabetes disproportionately affects communities of color. Type 2 diabetes
is prevalent at rates 2.6 times higher among American Indians and Alaska
Natives than among whites. African-American adults have a 100-percent higher
rate, and Hispanics a 90-percent higher rate, of type 2 diabetes than whites.
(9) The African-American and Hispanic death rates from diabetes are twice
that for whites. Among American Indians and Alaska Natives, the death rate
from diabetes is 3 times higher than for whites.
(10) More than 1 out of every 10 health care dollars, and at least 1 out
of 4 dollars provided under the medicare program carried out under title
XVIII of the Social Security Act, are spent on individuals in the United
States with diabetes.
(11) The economic cost of diabetes is conservatively estimated at $132,000,000,000
annually. This includes $92,000,000,000 in direct medical expenditures and
$40,000,000,000 attributable to disability and premature mortality.
(12) Reducing the progression of pre-diabetes to diabetes with the level
of success achieved by the National Institutes of Health's Diabetes Prevention
Program could save $4,290,000,000 annually.
TITLE I--CENTERS FOR DISEASE CONTROL AND PREVENTION
SEC. 101. COMPREHENSIVE STATE DIABETES CONTROL AND PREVENTION PROGRAMS.
Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.)
is amended by striking section 316 and inserting the following;
`SEC. 316. STATE DIABETES CONTROL AND PREVENTION PROGRAMS.
`(a) IN GENERAL- The Secretary, acting through the Director of the Centers
for Disease Control and Prevention and in consultation with appropriate agencies,
shall support comprehensive diabetes control and prevention programs by awarding
grants to eligible entities to provide public health surveillance, prevention,
and control activities, and to assure affordable, high-quality diabetes care.
`(b) ELIGIBILITY- A State or territory is an eligible entity under this section.
`(c) USE OF FUNDS- Consistent with the comprehensive diabetes control and
prevention plan submitted under subsection (d), an eligible entity that receives
a grant under this section may use funds received under such grant to--
`(1) conduct health and community research, including research on behavioral
interventions, to prevent type 1 and 2 diabetes (including the development
of related complications) and the onset of type 2 diabetes in persons with
pre-diabetes or persons at high risk for developing diabetes;
`(2) conduct demonstration projects, including community-based programs
of diabetes control and prevention, and similar collaborations with academic
institutions, hospitals, community centers, health insurers, researchers,
health professionals, and nonprofit organizations;
`(3) conduct public health surveillance and epidemiological activities relating
to the prevalence of type 1 and 2 diabetes and assessing disparities in
diabetes control and prevention, including such disparities in underserved
populations;
`(4) provide public information and education programs; and
`(5) provide education and training for health professionals, including
allied health professionals.
`(d) APPLICATION- An eligible entity that seeks funding under this section
shall submit an application to the Secretary at such time, in such manner,
and containing such information as the Secretary may require, including a
comprehensive plan for diabetes-related prevention and control strategies
and activities to be undertaken or supported by the eligible entity, which--
`(1) is developed with the advice of stakeholders from the public, private,
and nonprofit sectors with expertise relating to diabetes control, prevention,
and treatment;
`(2) is intended to reduce the incidence, morbidity, and mortality of type
1 and 2 diabetes, with a priority on preventing and controlling diabetes
in at-risk populations and reducing disparities in underserved populations;
and
`(3) describes the diabetes-related services and activities to be undertaken
or supported by the eligible entity.'.
SEC. 102. CDC DIABETES CONTROL AND PREVENTION ACTIVITIES.
Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.)
(as amended by section 101) is further amended by inserting after section
316, the following:
`SEC. 316A. DIABETES CONTROL, PREVENTION, AND RESEARCH ACTIVITIES.
`(a) IN GENERAL- The Secretary, acting through the Director of the Centers
for Disease Control and Prevention, and in collaboration with appropriate
agencies, shall conduct, support, and promote the coordination of research,
including translational and preventive investigations and studies, demonstrations
and pilot programs, training and studies relating to surveillance, control,
and prevention of type 1 and 2 diabetes (including the development of related
complications) and the onset of type 2 diabetes in persons with pre-diabetes
or persons at high risk for developing diabetes.
`(b) ACTIVITIES- Activities that the Secretary shall conduct, support, and
promote as described in subsection (a) shall include--
`(1) the collection, analysis, and publication of biennial data on the prevalence
and incidence of type 1 and 2 diabetes and of pre-diabetes, in coordination
with activities undertaken under section 317H;
`(2) the development of uniform data sets for public health surveillance
and clinical quality improvement activities;
`(3) the identification of evidence-based and cost-effective public health
best practices, including practices and models developed through grants
awarded under section 316;
`(4) the development of early detection and prevention programs, such as
screening to identify diabetic retinopathy and to prevent blindness, as
well as neuropathy, nephropathy, peripheral vascular disease, podiatric
examinations to prevent foot ulcers, and lower extremity amputations; and
`(5) the establishment and operation of a national diabetes laboratory to
develop and improve laboratory methods to assist in the diagnosis, treatment,
and prevention of diabetes, including the development of less invasive ways
to monitor blood glucose, such as nonmydriatic retinal imaging, and to prevent
hypoglycemia, and the improvement of existing glucometers that measure blood
glucose.
`(c) PRIORITY- The Secretary shall give priority to programs and activities
to reduce disparities in diabetes prevention, diagnosis, management, and care
for high-risk or underserved populations. Such programs and activities may
include--
`(1) refinement of the National Health and Nutrition Examination Survey
to address the lifestyle of such populations;
`(2) enhanced efforts to develop culturally appropriate interventions; and
`(3) strategies to enhance the quality, accuracy, and timeliness of diabetes-related
morbidity and mortality data for such populations.
`(d) COLLABORATIVE ACTIVITIES- The activities described in subsection (b)
may be conducted in collaboration with eligible entities that are awarded
a grant under section 316.
`(e) TRAINING AND TECHNICAL ASSISTANCE- The Secretary may provide training,
technical assistance, supplies, equipment, and services, and may detail any
officer or employee of the Department of Health and Human Services, to State
and local health agencies, or to any public or nonprofit entity designated
by a State health agency, with respect to the planning, development, and operation
of any program or service carried out pursuant to subsection (a) or in lieu
of grant funds provided under section 316.
`(f) IMPROVEMENT OF MORTALITY DATA COLLECTION-
`(1) ASSESSMENT- The activities described in subsection (b)(1) shall include
an assessment of diabetes as a primary or underlying cause of death and
analysis of any under-reporting of diabetes as a primary or underlying cause
of death in order to provide an accurate estimate of yearly deaths related
to diabetes.
`(2) DEATH CERTIFICATE ADDITIONAL LANGUAGE- In carrying out the activities
described in
subsection (b)(1), the Secretary may promote the addition of language to
death certificates to improve collection of diabetes mortality data, including
adding questions for the individual certifying to the cause of death regarding
whether the deceased had diabetes and whether diabetes was an immediate, underlying,
or contributing cause of or condition leading to death.
`(1) IN GENERAL- The Director shall submit to the Committee on Health, Education,
Labor, and Pensions of the Senate and the Committee on Energy and Commerce
of the House of Representatives annual reports describing the activities
undertaken under this section and section 316.
`(2) CONTENT- The reports shall include an--
`(A) evaluation of the accuracy of data regarding the incidence, prevalence,
complications, and costs of diabetes; and
`(B) projections regarding trends in each of the areas described in subparagraph
(A).
`(3) AVAILABILITY- The Director shall make such reports publicly available
in print and on the Centers for Disease Control and Prevention website.
`SEC. 316B. AUTHORIZATION OF APPROPRIATIONS.
`There are authorized to be appropriated to carry out sections 316 and 316A,
$120,000,000 for fiscal year 2004, and such sums as may be necessary for each
of fiscal years 2005 through 2008.'.
TITLE II--IMPROVING THE QUALITY OF DIABETES PREVENTION AND CARE
SEC. 201. DIABETES CARE QUALITY IMPROVEMENT GRANTS.
Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.)
(as amended by section 102) is further amended by inserting after section
316B the following:
`SEC. 316C. IMPROVING QUALITY OF DIABETES PREVENTION AND CARE.
`(a) IN GENERAL- After completion of activities under subsection (d), the
Secretary, acting through the Director of the Centers for Disease Control
and Prevention, and in collaboration with the Director of the Agency for Healthcare
Research and Quality, shall award competitive grants to eligible entities
to apply the best practices identified by the Secretary under subsection (d)
for diabetes prevention and control.
`(b) ELIGIBILITY- An entity is eligible for a grant under this section if
such entity is--
`(1) a State, territory, Indian tribe, tribal organization, public or nonprofit
entity; or
`(2) a partnership of an entity described in paragraph (1) and an appropriate
private sector organization.
`(c) PRIORITY- In awarding grants under this section, the Secretary shall
give priority to eligible entities that propose to carry out programs to reduce
disparities in diabetes prevention and control for high-risk or underserved
populations.
`(1) IN GENERAL- Not later than 1 year after the date of enactment of this
section, the Secretary shall identify evidence-based best practices, evidence-based
guidelines and other effective models for diabetes prevention and control,
which may be adopted and applied by eligible entities under this section.
`(2) SPECIFIC BEST PRACTICES- Best practices, as described in paragraph
(1), may include--
`(A) State or community-based interventions, school-based screening, care
and prevention programs, health systems improvement strategies, and health
and environmental policies that promote improved nutrition and physical
activity;
`(B) case management or disease management quality improvements programs;
`(C) appropriate communication, training, or regional outreach and health
promotion initiatives, including Internet-based initiatives; or
`(D) models developed or validated by diabetes research and training centers
established under section 431.
`(e) APPLICATION- An eligible entity that seeks funding under this section
shall prepare and submit to the Secretary an application at such time, in
such manner, and containing such information as the Secretary determines to
be necessary, including information regarding how such entity would use funds
received under this section to supplement activities carried out under such
entity's comprehensive diabetes control and prevention plan under section
316.
`(f) AUTHORIZATION OF APPROPRIATIONS- There are authorized to be appropriated
to carry out this section, $50,000,000 for fiscal year 2004, and such sums
as may be necessary for each of fiscal years 2005 through 2008.'.
SEC. 202. ENHANCEMENT OF DIABETES EDUCATION AND OUTREACH.
Part P of title III of the Public Health Service Act (42 U.S.C. 243 et seq.)
is amended by adding at the end the following:
`SEC. 399O. NATIONAL DIABETES EDUCATION AND OUTREACH.
`(a) PURPOSE- The Secretary, acting through the Diabetes Mellitus Interagency
Coordinating Committee, shall coordinate a national diabetes education program
to support, develop, and implement education initiatives and outreach strategies
appropriate for both type 1 and 2 diabetes. Such activities may include public
awareness campaigns, public service announcements and community partnership
workshops, as well as programs targeted at businesses and employers, managed
care organizations, and health care providers.
`(b) PRIORITY- The Secretary shall emphasize translation of new scientific
and clinical findings into utilizable information for health care providers
and patients. The Secretary shall also give priority to reaching high-risk
or underserved populations.
`(c) COLLABORATION- In carrying out this section, the Secretary shall consult
and collaborate with stakeholders from the public, private, and nonprofit
sectors
with expertise relating to diabetes control, prevention, and treatment.
`(d) AUTHORIZATION OF APPROPRIATIONS- There is authorized to be appropriated
to carry out this section, $15,000,000 for fiscal year 2004 and such sums
as may be necessary for each of fiscal years 2005 through 2008.'.
SEC. 203. DIABETES QUALITY MEASURES.
Section 912 of the Public Health Service Act (42 U.S.C. 299b-1) is amended
by adding at the end the following:
`(d) QUALITY MEASURES- In carrying out subsection (a), the Director shall--
`(1) develop and periodically update, lists of scientifically validated,
evidence-based quality measures for assessing and improving clinical services
and counseling related to diabetes; and
`(2) support the development and validation of needed measures.'.
SEC. 204. DIABETES QUALITY IMPROVEMENT PROGRAM.
(a) DIABETES QUALITY IMPROVEMENT PROGRAM- The Secretary of Health and Human
Services, acting through the Director of the Centers for Disease Control and
Prevention, shall establish a Diabetes Quality Improvement Program to disseminate
and promote the widespread use of national performance measures for diabetes
care and for quality improvement to all diabetes prevention and control programs
under the authority of the Secretary. The National Diabetes Quality Improvement
Program shall promote the adoption of these national performance measures
to public and private health care systems providing care to persons with diabetes
and expand the number and scope of public-private partnerships implementing
such Program.
(b) EVALUATION- The Secretary of Health and Human Services, acting through
the Director of the Agency for Healthcare Research and Quality and the Director
of the Centers for Disease Control and Prevention, shall undertake an evaluation
of quality improvement initiatives supported under this section.
(c) AUTHORIZATION OF APPROPRIATIONS- There are authorized to be appropriated
to carry out this section, such sums as may be necessary for each of fiscal
years 2004 through 2008.
SEC. 205. MONITORING THE QUALITY AND DISPARITIES IN DIABETES CARE.
Part A of title IX of the Public Health Service Act (42 U.S.C. 299 et seq.)
is amended by adding at the end the following:
`SEC. 904. AREAS OF SPECIAL EMPHASIS.
`The Secretary, acting through the Director, shall incorporate within the
annual quality report required under section 913(b)(2) and the annual disparities
report required under section 903(a)(6), scientific evidence and information
appropriate for monitoring the quality and safety of diabetes care and identifying,
understanding, and reducing disparities in care.'.
TITLE III--NATIONAL INSTITUTES OF HEALTH
SEC. 301. ENHANCEMENT OF DIABETES RESEARCH AND TRAINING CENTERS.
(a) IN GENERAL- Section 431(a)(1) of the Public Health Service Act (42 U.S.C.
285c-5(a)(1)) is amended by striking `Consistent with applicable recommendations
of the National Commission on Diabetes,' and inserting `Consistent with applicable
recommendations of the Diabetes Research Working Group and with updated strategic
research plans developed through the Diabetes Mellitus Interagency Coordinating
Committee,'.
(b) AUTHORIZED RESEARCH- Section 431(a)(1)(B)(i) of the Public Health Service
Act (42 U.S.C. 285c-5(a)(1)(B)(i)) is amended by inserting `basic, clinical,
behavioral, translational, and preventative' before `research'.
(c) EDUCATION AND TRAINING- Section 431(a)(2) of the Public Health Service
Act (42 U.S.C. 285c-5(a)(2)) is amended by striking `paragraph (1)(B)(ii).'
and inserting `paragraph (1)(B)(ii). Such funds may also be used for pre-
and post-doctoral research fellowship training and for research career development,
meeting such requirements as the Secretary may prescribe.'.
SEC. 302. DIABETES RESEARCH PLANNING AND COORDINATION.
Section 429 of the Public Health Service Act (42 U.S.C. 285c-3) is amended
by adding at the end the following:
`(d) The Diabetes Mellitus Interagency Coordinating Committee shall develop
and periodically update a strategic research plan for diabetes, building upon
and updating the overall scientific guidance provided by the 1999 Strategic
Plan of the congressionally established Diabetes Research Working Group. In
engaging in strategic research planning for diabetes, the Committee shall
address broad, multiple avenues of current and emerging research needs and
opportunity, including clinical research in diabetes, the genetics of diabetes,
diabetes in children and youth, and diabetes in underserved or high-risk populations.
The Committee shall also coordinate the efforts of the National Diabetes Education
Program.'.
SEC. 303. GENETICS OF DIABETES.
Title IV of the Public Health Service Act (42 U.S.C. 281 et seq.) is amended
by inserting after section 430 the following:
`SEC. 430A. GENETICS OF DIABETES.
`The Diabetes Mellitus Interagency Coordinating Committee, in collaboration
with the Directors of the National Human Genome Research Institute, the National
Institute of Diabetes and Digestive and Kidney Diseases, and the National
Institute of Environmental Health Sciences, and other voluntary organizations
and interested parties, shall--
`(1) coordinate and assist efforts of the Type 1 Diabetes Genetics Consortium,
which will collect and share valuable DNA information from type 1 diabetes
patients from studies around the world; and
`(2) provide continued coordination and support for the consortia of laboratories
investigating the genomics of diabetes.'.
SEC. 304. RESEARCH AND TRAINING ON DIABETES IN UNDERSERVED AND MINORITY
POPULATIONS.
(a) RESEARCH- Subpart 3 of part C of title IV of the Public Health Service
Act (42 U.S.C. 285c et seq.) is amended by adding at the end the following:
`SEC. 434B. RESEARCH ON DIABETES IN UNDERSERVED AND MINORITY POPULATIONS.
`(a) IN GENERAL- The Director of the Institute, in coordination with the Director
of the National Center on Minority Health and Health Disparities and other
appropriate institutes and centers, shall expand, intensify, and coordinate
research programs on pre-diabetes, type 1 diabetes and type 2 diabetes in
underserved populations and minority groups.
`(b) RESEARCH- The research described in subsection (a) shall include research
on--
`(1) behavior, including diet and physical activity and other aspects of
behavior;
`(2) environmental factors related to type 2 diabetes that are unique to,
more serious, or more prevalent, among underserved or high-risk populations;
`(3) research on the prevention of complications, which are unique to, more
serious, or more prevalent among minorities, as well as research on how
to effectively translate the findings of clinical trials and research to
improve methods for self-management and health care delivery; and
`(4) genetic studies of diabetes, consistent with research conducted under
section 430A.
`(c) DEFINITION- In this section, the term `minority group' has the meaning
given the term `racial and ethnic minority group' in section 1707.
`(d) AUTHORIZATION OF APPROPRIATIONS- There are authorized to be appropriated
for purposes of carrying out this section $20,000,000 for fiscal year 2004
and such sums as may be necessary for each of fiscal years 2005 through 2008.'.
(b) DIVISION DIRECTORS- Section 428 of the Public Health Service Act (42 U.S.C.
285c-2) is amended--
(1) in subsection (b)(1), by inserting `(including research training of
members of minority populations in order to facilitate their conduct of
diabetes-related research in underserved populations and minority groups)'
after `research programs'; and
(2) by adding at the end the following:
`(c) DEFINITION OF MINORITY GROUP- In this section, the term `minority group'
has the meaning given the term `racial and ethnic minority group' in section
1707.'.
SEC. 305. AUTHORIZATION OF APPROPRIATIONS.
Subpart 3 of part C of title IV of the Public Health Service Act (42 U.S.C.
285c et seq.) (as amended by section 304(a)) is amended by adding at the end
the following:
`SEC. 434C. AUTHORIZATION OF APPROPRIATIONS.
`For the purpose of carrying out this subpart with respect to the programs
of the National Institute of Diabetes and Digestive and Kidney Diseases, other
than section 434B, there are authorized to be appropriated such sums as may
be necessary for each of fiscal years 2004 through 2008.'.
TITLE IV--REDUCING DIABETES AMONG CHILDREN AND YOUTH
SEC. 401. PROGRAMS OF CENTERS FOR DISEASE CONTROL AND PREVENTION.
Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.)
is amended by striking section 317H and inserting the following:
`SEC. 317H. DIABETES IN CHILDREN AND YOUTH.
`(a) Surveillance on Type 1 Diabetes- The Secretary, acting through the Director
of the Centers for Disease Control and Prevention and in consultation with
the Director of the National Institutes of Health, shall develop a sentinel
system to collect data on type 1 diabetes, including the incidence and prevalence
of type 1 diabetes and shall establish a national database for such data.
`(b) Type 2 Diabetes in Youth- The Secretary shall implement a national public
health effort to address type 2 diabetes in youth, including--
`(1) enhancing surveillance systems and expanding research to better assess
the prevalence and incidence of type 2 diabetes in youth and determine the
extent to which type 2 diabetes is incorrectly diagnosed as type 1 diabetes
among children;
`(2) standardizing and improving methods to assist in the diagnosis, treatment,
and prevention of diabetes including developing less invasive ways to monitor
blood glucose to prevent hypoglycemia such as nonmydriatic retinal imaging
and improving existing glucometers that measure blood glucose; and
`(3) developing methods to identify obstacles facing children in traditionally
underserved populations to obtain care to prevent or treat type 2 diabetes.
`(c) LONG-TERM EPIDEMIOLOGICAL STUDIES ON DIABETES IN CHILDREN- The Secretary,
acting through the Director of the Centers for Disease Control and Prevention
and the Director of the National Institute of Diabetes and Digestive and Kidney
Diseases, shall conduct or support long-term epidemiology studies in children
with diabetes or at risk for diabetes. Such studies shall investigate the
causes and characteristics of the disease and its complications.
`(d) AUTHORIZATION OF APPROPRIATIONS- There are authorized to be appropriated
to carry out this section, $20,000,000 for fiscal year 2004 and such sums
as may be necessary for each of fiscal years 2005 through 2008.'.
SEC. 402. PROGRAMS OF NATIONAL INSTITUTES OF HEALTH.
Subpart 3 of part C of title IV of the Public Health Service Act (42 U.S.C.
285c et seq.) is amended by striking section 434A and inserting the following:
`SEC. 434A RESEARCH ON DIABETES IN CHILDREN AND YOUTH.
`(a) IN GENERAL- Consistent with the Pediatric Research Initiative established
under section 409D, the Director of the Institute shall expand, intensify,
and coordinate research programs and efforts of the National Institutes of
Health to treat, cure, and prevent diabetes in children.
`(b) CLINICAL TRIAL INFRASTRUCTURE; INNOVATIVE TREATMENTS- The Secretary,
acting through the Director of the National Institutes of Health, shall support
clinical research centers and testing of innovative treatments for the prevention,
detection, treatment, and cure of diabetes. Such treatments may include testing
of islet cell transplantation, new insulin preparations, insulin delivery
methods, and blood sugar monitoring devices.
`(c) PREVENTION OF DIABETES- The Secretary, acting through the appropriate
agencies, shall provide for a national effort to prevent diabetes. Such effort
shall provide for a combination of increased research and development of prevention
strategies, such as consideration of vaccine development, coupled with the
appropriate ability to test the effectiveness of such strategies in clinical
trials, including strategies to prevent the onset and progression of type
1 diabetes.
`(d) AUTHORIZATION OF APPROPRIATIONS- There are authorized to be appropriated
to carry out this section such sums as may be necessary for each of fiscal
years 2004 through 2008.'.
TITLE V--REPORTS
SEC. 501. SURGEON GENERAL'S REPORT ON THE PUBLIC HEALTH IMPACT OF DIABETES.
(a) IN GENERAL- The Surgeon General may prepare a report on diabetes, including
the prevalence of diabetes and the adequacy of data collection and analysis
concerning diabetes.
(b) CONTENTS- The report described in subsection (a) shall--
(1) set forth recommendations to address underserved and high-risk populations;
(2) set forth recommendations to reduce the morbidity, mortality, and prevalence
of diabetes in the United States; and
(3) contain an action plan to implement the recommendations under paragraphs
(1) and (2).
(b) ISSUANCE OF REPORT- Not later than 3 years after the date of enactment
of this Act, the Surgeon General shall submit to the Committee on Health,
Education, Labor, and Pensions of the Senate and the Committee on Energy and
Commerce of the House of Representatives the report described in subsection
(a).
(c) DEFINITION OF DIABETES- In this section, the term `diabetes' means type
1 diabetes and its complications, type 2 diabetes and its complications, and
pre-diabetes or impaired glucose tolerance.
(d) AUTHORIZATION OF APPROPRIATIONS- There are authorized to be appropriated
to carry out this section $1,000,000 for fiscal year 2004, and such sums as
may be necessary for each of fiscal years 2005 and 2006.
END